Equities research analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a report issued on Thursday. The brokerage set a “buy” rating on the stock.
Mannatech Stock Performance
Shares of MTEX opened at $10.43 on Thursday. The firm has a fifty day moving average of $8.55 and a 200-day moving average of $7.79. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.25. The company has a market cap of $19.61 million, a price-to-earnings ratio of -12.88 and a beta of 1.18. Mannatech has a 1 year low of $6.75 and a 1 year high of $13.00.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The firm had revenue of $31.73 million during the quarter.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- The Risks of Owning Bonds
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Transportation Stocks Investing
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.